The U.S. dialyzers market is expected to witness significant growth in the forecast period due to the increasing prevalence of end-stage renal disease (ESRD) and growing geriatric population. Technological advancements in dialysis machines and increasing healthcare expenditure are also contributing to market growth.
Two growth drivers for the U.S. dialyzers market include the rising number of patients with ESRD and the increasing adoption of home dialysis treatments. These factors are creating a positive impact on the market growth by increasing the demand for dialyzers and related products.
Segment Analysis
The U.S. dialyzers market can be segmented based on type, material, and end-user. By type, the market is divided into synthetic dialyzers and cellulose-based dialyzers. In terms of material, the market is categorized into high-flux and low-flux dialyzers. The end-user segment includes hospitals, dialysis centers, and home care settings.
Competitive Landscape
The U.S. dialyzers market is highly competitive with the presence of both established players and new entrants. Key players in the market are focusing on product innovation, strategic collaborations, and acquisitions to strengthen their market position. Some of the leading companies in the U.S. dialyzers market include Fresenius Medical Care, Baxter International Inc., Nipro Corporation, Asahi Kasei Corporation, and B. Braun Melsungen AG.